The serum concentrations of ferritin and adiponectin are associated with several metabolic disorders and have been used as predictors of insulin resistance and metabolic syndrome. But there have been no reports demonstrating a direct correlation between serum ferritin and adiponectin levels. We performed this study to evaluate the association between serum ferritin and adiponectin concentrations.
Introduction
The serum ferritin concentration reflects the body's iron stores [1] . In previous studies, elevated serum ferritin levels were associated with several metabolic disorders. In a population study of Finnish men, serum ferritin levels were correlated with fasting serum glucose and insulin concentrations [2] . In a cross-sectional study of US adults, elevated iron stores were positively associated with the prevalence of metabolic syndrome and with insulin resistance [3] . And in several other studies, researchers found that elevated serum ferritin concentrations were associated with cardiovascular disease [4, 5] , diabetes mellitus [6] , gestational diabetes mellitus [7] , and central adiposity [8, 9] .
Adiponectin, one of the adipocytokines, is secreted from adipose tissue [10] . Previous studies have reported that adiponectin plays a significant role in metabolic homeostasis [11] . Decreased serum adiponectin concentrations have been observed in patients with insulin resistance [12, 13] , diabetes mellitus [14] , dyslipidemia [15] , and metabolic syndrome [13, 16] . Based on these results, the serum adiponectin level is considered a predictor of such metabolic disorders.
Both serum ferritin and adiponectin levels were useful predictors of insulin resistance and metabolic syndrome [3, 13] . But there are no reports demonstrating a direct correlation between serum ferritin and adiponectin levels. Therefore we evaluated the association between serum ferritin and adiponectin levels in normal and diabetic patients.
Materials and methods

Study population
Our study population comprised an age-and sexstratified random sample from the Korea Rural Genomic Cohort Study (Geumsan County). We conducted a population-based cross-sectional study. From January to February 2006, we studied a total of 995 subjects (417 males and 578 females) aged 40 to 80 years old (mean age 58.3 ± 7.7 years). Of the 995 subjects, 52 patients were excluded: those with any type of malignancy, those taking drugs that affect adiponectin level such as thiazolidinediones, and those with anemia, which was defined as a hemoglobin level less than 12 g/dl, or with iron deficiency anemia, which was classified by serum ferritin cutoff of 10 ng/ml in accordance with the World Health Organization definition [17] . Data from the remaining 943 subjects were analyzed, and data from 162 patients with diabetes mellitus were subanalyzed. Diabetes mellitus was diagnosed according to the criteria of the American Diabetes Association [18] or by the use of hypoglycemic agents.
Extensive clinical and laboratory screening was conducted for all participants. All participants gave their informed consent before entering the study. History and physical examination were obtained by personal interview. Blood pressure was measured on the right arm after at least 10 minutes of rest in a sitting position, using a standard mercury manometer. Height and weight were measured when the subjects were wearing light clothing and no shoes. Body mass index (BMI) was calculated as weight (kg) divided by the square of the height (m 2 ). After these examinations, blood samples were drawn after an overnight fast. Blood specimens were stored at 4
• C and analyzed within 4 hours after collection.
Laboratory experiments
Complete blood counts were obtained using a Coulter counter (Coulter Electronics, Hialeah, FL, USA).
Triglyceride, total cholesterol, and HDL-cholesterol were measured enzymatically using a chemistry analyzer (Hitachi 747, Tokyo, Japan). LDL-cholesterol was calculated using the Friedewald formula [19] . Fasting plasma glucose was measured by the glucose oxidase method. Insulin was measured by immunoradiometric assay (Diabetes Primary Care, Los Angeles, CA, USA). Intra-assay coefficient of variation ranged from 2.41 to 2.93%. Adiponectin was measured by radioimmunoassay (LINCO Research, Inc., St. Charles, MO, USA). Intra-assay coefficient of variation ranged from 7.55 to 14.26%. Homeostasis model assessment (HOMA) estimate of insulin resistance was determined by the formula:
High-sensitive C-reactive protein (hs-CRP) and ferritin were measured by enzyme immunoassay (Siemens Healthcare Diagnostics, Deerfield, IL, USA). Intra-assay coefficient of variation ranged from 2.11 to 3.00% in hs-CRP and from 5.0 to 10.0% in ferritin.
Statistical analysis
Continuous variables were expressed as the mean ± standard deviation. Statistical analysis was performed using the commercially available program, Statistical Package for the Social Sciences (SPSS ) (version 13.0; Chicago, IL, USA) for Windows . Comparisons between groups were performed using unpaired t-test or the chi-square test as appropriate. Linear regression analysis using the "stepwise" method was performed to evaluate the association between adiponectin and other clinical variables. A P value of less than 0.05 was considered statistically significant.
Results
Characteristics of the study population
The clinical characteristics are listed in Table 1 . The serum ferritin concentration was 108.0 ± 107.4 µg/L in all subjects, 102.2 ± 105.6 µg/L in non-diabetic subjects, and 135.3 ± 112.1 µg/L in diabetic subjects. The serum ferritin concentration in diabetic subjects was significantly higher than in non-diabetics (p = 0.029). The serum adiponectin concentration was 11.58 ± 5.63 µg/mL in all subjects, 11.96 ± 5.70 µg/mL in non-diabetic subjects, and 9.72 ± 4.91 µg/mL in diabetic subjects. The serum adiponectin concentration in diabetic subjects was significantly lower than in nondiabetics (p = 0.032). 
Correlation between serum adiponectin level and other parameters in all subjects
Univariate analysis (Table 2 ) revealed that the serum adiponectin level was correlated with conventional clinical variables, including age, sex, BMI, diastolic blood pressure, triglyceride, HDL-cholesterol, fasting blood glucose, fasting insulin, and hs-CRP. HOMA-IR, which serves as an indicator of insulin resistance, was significantly correlated with the serum adiponectin concentration (p < 0.001). Moreover, serum ferritin concentration was also significantly correlated with the serum adiponectin level (p < 0.001). The correlation of adiponectin to ferritin levels as a scatter-plot diagram was presented in Fig. 1 . After adjusting for age and sex, the serum adiponectin level was still correlated with BMI, triglyceride, HDL-cholesterol, fasting blood glucose, fasting insulin, HOMA-IR, hs-CRP, and serum ferritin concentration.
Multivariate analysis (Table 3 ) demonstrated that 
(C) Fig. 1 . Correlation of adiponectin to ferritin levels in (A) all subjects, (B) non-diabetic subjects, and (C) diabetic subjects. Scatter-plot diagram. 
Correlation between serum adiponectin level and other parameters in non-diabetic subjects
In non-diabetic subgroups, univariate analysis (Table 4) revealed that the serum adiponectin concentration was correlated with clinical variables, including age, sex, BMI, triglyceride, HDL-cholesterol, fasting blood glucose, fasting insulin, HOMA-IR, hs-CRP and serum ferritin concentration.
Multivariate analysis (Table 5 ) demonstrated that the serum adiponectin concentration was significantly correlated with BMI, triglyceride, HDL-cholesterol, fasting glucose and serum ferritin concentration.
Correlation between serum adiponectin level and other parameters in diabetic subjects
In diabetic subgroups, univariate analysis (Table 6 ) revealed that the serum adiponectin concentration was correlated with clinical variables, including sex, BMI, triglyceride, HDL-cholesterol, fasting blood glucose, fasting insulin, HOMA-IR, hs-CRP and serum ferritin concentration.
Multivariate analysis (Table 7) demonstrated that the serum adiponectin concentration was significantly correlated with BMI, triglyceride, hs-CRP and serum ferritin concentration.
Discussion
In this study, we demonstrated a significant correlation between serum ferritin concentration and serum adiponectin concentration. The serum ferritin concentration was inversely correlated with the serum adiponectin concentration. Adiponectin is a cytokine that is secreted from adipose tissue [11, 20, 21] . Adiponectin, also termed Acrp30, AdipoQ, or GBP28, structurally belongs to the complement q1 family and exists in blood as several types of multimers. Like changes in other adipocytokines, changes in the adiponectin level are related to several metabolic disorders.
According to a previous study, the serum level of adiponectin is associated with many clinical parameters. BMI, high-density lipoprotein, log triglyceride, fasting glucose, fasting insulin, fasting Cpeptide, and HOMA-IR were significantly correlated with adiponectin in African and Caucasian women [22] . BMI, HDL, apolipoprotein A1, apolipoprotein A2, plasminogen activator inhibitor-1 activity, TNF-α, and CRP were related to adiponectin in German patients [23] . BMI, fasting glucose, fasting insulin, HDL, triglyceride, CRP, insulin sensitivity, and visceral and subcutaneous adipose tissues were related to adiponectin in Hispanics and African-Americans [24] . BMI, fasting insulin, HDL and free fatty acids were also related to adiponectin in Japanese subjects [25] . Our results are similar to those of other studies. In our study, the concentration of adiponectin was related to BMI, triglyceride, HDL-cholesterol, fasting blood glucose, insulin, HOMA-IR, ferritin, and hs-CRP in univariate analysis. In multivariate analysis, age, BMI, fasting blood glucose, hs-CRP and ferritin were related to the serum adiponectin concentration. Ferritin was most powerfully correlated with adiponectin among these variables. To our knowledge, there are no previous reports about a direct correlation between ferritin and adiponectin.
In diabetic subjects, the adiponectin concentration was related to many clinical parameters. In Japanese diabetic subjects, BMI and triglyceride were correlated with adiponectin [26] . In US men with type 2 diabetes, HbA1c, TG, HDL, LDL, apoB100, CRP, and fibrinogen were correlated with adiponectin [27] . In our study, the adiponectin concentration was related to BMI, triglyceride, hs-CRP and ferritin in multivariate analysis. Triglyceride was most strongly correlated with the adiponectin concentration. In the case of ferritin, Sun et al. [28] reported that the adiponectin con-centration decreased according to the quartile of ferritin. However, they defined ferritin levels by quartiles, not by real values. The adiponectin concentration in diabetic subjects was significantly lower than in nondiabetic subjects, and the ferritin level in diabetic subjects was significantly higher than in non-diabetic subjects [6, 14, 26] . Our results are similar to those from other studies.
In conclusion, we demonstrated that ferritin is inversely correlated with serum adiponectin in all, nondiabetic and diabetic subjects. The biological mechanism for this association is not clear, but we can find one possible explanation in previous reports. Hypoadiponectinemia causes insulin resistance [10, 11] and hyperinsulinemia stimulates ferritin synthesis [29] . Hence we can hypothesize that hypoadiponectinemia can increase ferritin level. Decreased adiponectin levels are associated with many metabolic disorders [12] [13] [14] [15] [16] and some cancers [30, 31] . Thus we can use the serum adiponectin concentration as a predictor of such diseases. But the serum adiponectin level varies with measurement conditions such as storage time and temperature [32] . Therefore, if we use both ferritin and adiponectin levels, we can more accurately predict the development of several metabolic disorders and cancers.
This study has some limitations. We performed a cross-sectional study and measured total adiponectin levels, rather than low and high molecular forms. Also we did not determine the cutoff values of adiponectin and ferritin levels for predicting several metabolic diseases. Further studies are required to overcome these limitations.
